With the advantages of high sensitivity, low sample consumption, and short experiment time, MST technology is suitable for high-throughput screening (HTS) and fragment-based screening (FBS) in the early stage of drug discovery. Creative Biostructure has been one of the first enterprises to master the latest techniques with forward-looking insights into the development of structure-guided drug discovery. We have established many reliable approaches to meet your drug discovery program requirements. We can provide MST, a relatively new methodology for quantifying biomolecular interactions to assist screen and characterize hit compounds.